A UK Vision for Stratified Medicine

A UK Vision for Stratified Medicine

The Stratified Medicine Innovation Platform partners have worked with a broad spectrum of stakeholders to develop a national vision for stratified medicine. The vision is for the UK to be the best place to develop, and have adopted, stratified medicine.

A UK Vision for Stratified Medicine

• The UK should be the best place to develop, and have adopted, stratified medicine. This will benefit patients, provide cost effect solutions for NHS and other healthcare providers and create opportunities for business.

• There should be an increased collaborative culture throughout the sector based around shared resources, and systems should be in place for effective data collection, sharing, governance and use across sectors (including, NHS, business, academia, regulators and NICE)

• It should be faster and less expensive to develop new drug-diagnostic combinations and have them licensed, and success should be reflected in increased UK economic growth.

• All NHS Patients who wish to should be able to be involved in medical research, including through patient information and records, to inform the next generation of successful therapies

• There should be a smooth reimbursement process, for stratified therapies and diagnostics,  and an IP framework that encourages innovation

• The UK health system should have established stratified care pathways, and evidence should be available to show that patient outcomes are improved where stratified medicine is used

A technology roadmap has been developed to help deliver upon this vision. A technology roadmap is a plan that matches short-term and long-term goals with specific technology solutions to help meet those goals. It can be used to guide the development of new products, processes or services, and to help shape the future direction of an emerging technology. Developing a roadmap has three major uses. It helps reach a consensus about a set of needs and the technologies required to satisfy those needs; it provides a mechanism to help forecast technology developments, and it provides a framework to help plan and coordinate technology developments.

 The Stratified Medicine technology roadmap describes thematic areas which, if advanced successfully, will help accelerate the development and uptake of stratified medicine within the UK.  The themes were identified at a series of workshops attended by individuals representing a broad stakeholder community including commercial companies, large and small developing therapeutics, diagnostics and data handling solutions; representatives from healthcare sector including clinicians from across a number of therapeutic areas, pathologists, commissioners and managers as well as representatives from public sector policy bodies.  In addition there were academics covering all of the major topics which would be represented in research around stratification of patients.  The roadmap captures the range of views expressed by this broad group of stakeholders.  It calls for activity in nine thematic areas:

The UK Stratified Medicine Roadmap: The Nine Themes

1. Incentivising adoption
2. Increasing Awareness
3. Patient recruitment – consents and ethics
4. Clinical trials
5. Data – collection, management and use
6. Regulation and standards
7. Intellectual Property
8. Bio-banks and biomarkers
9. Increasing the impact of R&D investment

 All of the partners are contributing significantly to the Innovation Platform and helping to implement the roadmap and achieve the vision.

Last updated on Thursday 08 December 2011 at 16:12

Copyright © 2013